1,3-dipropyl-8-cyclopentylxanthine has been researched along with glyburide in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (45.16) | 18.2507 |
| 2000's | 11 (35.48) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Abiko, Y; Hara, A | 1 |
| Akatsuka, Y; Egashira, K; Katsuda, Y; Narishige, T; Shimokawa, H; Takeshita, A; Ueno, H | 1 |
| Martin, PL; Potts, AA | 1 |
| Gross, GJ; Yao, Z | 1 |
| Auchampach, JA; Gross, GJ | 1 |
| Armstrong, SC; Downey, JM; Ganote, CE; Liu, GS | 1 |
| Fujino, M; Fujiwara, S; Kojima, M; Kusumoto, K; Watanabe, T | 1 |
| Baird, AJ; Grover, GJ; Sleph, PG | 1 |
| Gäbel, J; Lebrun, P; Malaisse, WJ; Pirotte, B; Rorsman, P; Valverde, I; Van Poelje, PD; Villanueva-Peñacarrillo, ML; Viñambres, C | 1 |
| Krnjević, K; Zhu, PJ | 1 |
| Forrest, CR; He, W; Neligan, P; Pang, CY; Xu, H; Zhong, A | 1 |
| Hwang, TL; Liu, SI; Wu, SN | 1 |
| Blondeau, N; Heurteaux, C; Lazdunski, M; Plamondon, H | 1 |
| Aoki, M; Narimatsu, E | 1 |
| Lasley, RD; Mentzer, RM; Narayan, P | 1 |
| Chen, S; Fan, ZZ; He, RR | 1 |
| Grbović, L; Pesić, S; Prostran, M; Radenković, M | 1 |
| Chen, S; He, RR; Li, DP | 1 |
| Nowak, TS; Sorimachi, T | 1 |
| Ikomi, F; Kousai, A; Mizuno, R; Ohhashi, T | 1 |
| Goto, W; Hirao, M; Ikeda, T; Kobayashi, T; Oku, H; Sugiyama, T | 1 |
| Kogi, K; Konno, T; Nagai, A; Nakahata, N; Uchibori, T | 1 |
| Berg, G; D'Annunzio, V; Donato, M; Gelpi, RJ; Gonzalez, G; Morales, C; Schreier, L; Wikinski, RL | 1 |
| Chen, SR; Li, DP; Pan, HL | 1 |
| Garrison, RN; Harris, PD; Li, N; Matheson, PJ; Zakaria, el R | 1 |
| Althani, A; Fawzi, AA; Fituri, OM; Zakaria, el R | 1 |
| Nieoczym, D; Pieróg, M; Socała, K; Wlaź, P | 1 |
31 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and glyburide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Protective effect of hypoxia on mechanical and metabolic changes induced by hydrogen peroxide in rat hearts.
Topics: Animals; Glyburide; Heart; Hydrogen Peroxide; Hypoxia; In Vitro Techniques; Male; Myocardium; Purinergic Antagonists; Rats; Theophylline; Xanthines | 1995 |
ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog.
Topics: Acetylcholine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Colforsin; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Glyburide; Guanidines; Ion Channel Gating; Pinacidil; Potassium Channels; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P2; Theophylline; Vasodilator Agents; Xanthines | 1994 |
The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5'-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Arginine; Endothelium, Vascular; Glyburide; In Vitro Techniques; Indomethacin; Isoproterenol; Male; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Renal Artery; Renal Circulation; Theophylline; Vasodilator Agents; Xanthines | 1994 |
Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.
Topics: Adenosine; Adenosine Triphosphate; Animals; Dogs; Female; Glyburide; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Phenethylamines; Potassium Channels; Purinergic Antagonists; Receptors, Purinergic; Xanthines | 1993 |
Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs.
Topics: Adenosine; Adenosine Triphosphate; Animals; Blood Glucose; Coronary Circulation; Coronary Disease; Dogs; Female; Glyburide; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion; Potassium Channels; Purines; Receptors, Purinergic; Sulfonamides; Xanthines | 1993 |
Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil.
Topics: Analysis of Variance; Animals; Cells, Cultured; Glyburide; Guanidines; Heart; Hypoglycemic Agents; Kinetics; Myocardial Ischemia; Pinacidil; Potassium Channels; Purinergic P1 Receptor Antagonists; Rabbits; Time Factors; Vasodilator Agents; Xanthines | 1995 |
Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044.
Topics: Animals; Dogs; Endothelin Receptor Antagonists; Endothelins; Glyburide; Male; Myocardial Infarction; Peptides, Cyclic; Rabbits; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1995 |
Lack of a pharmacologic interaction between ATP-sensitive potassium channels and adenosine A1 receptors in ischemic rat hearts.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Male; Myocardial Ischemia; Myocardium; Perfusion; Phenylisopropyladenosine; Potassium Channels; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Xanthines | 1996 |
The riddle of formycin A insulinotropic action.
Topics: Adenosine; Animals; Calcium; Diabetes Mellitus, Type 2; Diazoxide; Female; Formycins; Glucose; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Rats; Ribonucleotides; Tubercidin; Verapamil; Xanthines | 1996 |
Adenosine release mediates cyanide-induced suppression of CA1 neuronal activity.
Topics: Adenosine; Animals; Dipyridamole; Evoked Potentials; Excitatory Postsynaptic Potentials; Glyburide; Hippocampus; In Vitro Techniques; Male; Neurons; Potassium Cyanide; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Synapses; Theophylline; Xanthines | 1997 |
Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction.
Topics: Adenosine; Animals; Decanoic Acids; Glyburide; Hydroxy Acids; Infarction; Ischemia; Ischemic Preconditioning; Muscle, Skeletal; Neutrophils; Peroxidase; Phenylisopropyladenosine; Potassium Channel Blockers; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Reperfusion; Swine; Time Factors; Xanthines | 1997 |
Activation of muscarinic K+ channels by extracellular ATP and UTP in rat atrial myocytes.
Topics: Acetylcholine; Adenosine; Adenosine Triphosphate; Animals; Dose-Response Relationship, Drug; Extracellular Space; Glyburide; GTP-Binding Proteins; Heart Atria; In Vitro Techniques; Kinetics; Patch-Clamp Techniques; Pertussis Toxin; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Receptors, Purinergic; Uridine Triphosphate; Virulence Factors, Bordetella; Xanthines | 1998 |
Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels.
Topics: Animals; Disease Models, Animal; DNA Fragmentation; Epilepsy; Glyburide; Hippocampus; In Situ Nick-End Labeling; Ischemic Attack, Transient; Ischemic Preconditioning; Kainic Acid; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Phenylisopropyladenosine; Potassium Channels; Purinergic P1 Receptor Antagonists; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Purinergic P1; Time Factors; Xanthines | 1999 |
Transient depression of excitatory synaptic transmission induced by adenosine uptake inhibition in rat hippocampal slices.
Topics: Adenosine; Aminophylline; Analgesics; Animals; Bicuculline; Dipyridamole; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Feedback; GABA Antagonists; Glyburide; Hippocampus; Hypoglycemic Agents; Male; Naphthalenes; Neomycin; Neurons; Neurotransmitter Agents; Phosphodiesterase Inhibitors; Protein Kinase C; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Receptors, Purinergic P1; Synaptic Transmission; Xanthines | 2000 |
Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.
Topics: Adenosine; Aniline Compounds; Animals; Calcium; Decanoic Acids; Drug Synergism; Fluoresceins; Fluorescent Dyes; Glyburide; Heart Ventricles; Hydroxy Acids; Ion Transport; Male; Microscopy, Fluorescence; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Oxidation-Reduction; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Purinergic P1; Xanthenes; Xanthines | 2001 |
[Adenosine facilitates carotid baroreflex in rats].
Topics: Adenosine; Animals; Baroreflex; Blood Pressure; Carotid Sinus; Female; Glyburide; In Vitro Techniques; Male; Potassium; Potassium Channel Blockers; Potassium Channels; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Xanthines | 1998 |
Characterization of adenosine action in isolated rat renal artery. Possible role of adenosine A(2A) receptors.
Topics: Adenosine; Animals; Caffeine; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Indomethacin; Isotonic Solutions; Male; Models, Animal; Muscle Relaxation; Nitroarginine; Potassium Chloride; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Renal Artery; Tetraethylammonium; Vasodilator Agents; Xanthines | 2000 |
Effects of microinjection of adenosine into area postrema on heart rate, blood pressure and renal sympathetic nerve activity in rats.
Topics: Adenosine; Animals; Blood Pressure; Glyburide; Heart Rate; Kidney; Medulla Oblongata; Microinjections; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Theophylline; Xanthines | 2000 |
Pharmacological manipulations of ATP-dependent potassium channels and adenosine A1 receptors do not impact hippocampal ischemic preconditioning in vivo: evidence in a highly quantitative gerbil model.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Female; Gerbillinae; Glyburide; Hippocampus; Ischemic Preconditioning; Membrane Potentials; Potassium Channels; Receptor, Adenosine A1; Xanthines | 2004 |
ATP inhibits pump activity of lymph vessels via adenosine A1 receptor-mediated involvement of NO- and ATP-sensitive K+ channels.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Antineoplastic Agents; Arginine; Cardiovascular Agents; Endothelium; Enzyme Inhibitors; Glyburide; Indomethacin; Lymphatic System; Male; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Rats; Rats, Wistar; Receptor, Adenosine A1; Suramin; Xanthines | 2004 |
Effects of adenosine on optic nerve head circulation in rabbits.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine A1 Receptor Antagonists; Adenylyl Cyclase Inhibitors; Animals; Caffeine; Capillaries; Dose-Response Relationship, Drug; Glyburide; Injections; Injections, Intravenous; Optic Disk; Phenethylamines; Potassium Channels; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rabbits; Regional Blood Flow; Stimulation, Chemical; Vasodilation; Vitreous Body; Xanthines | 2004 |
2-(1-Hexyn-1-yl)adenosine-induced intraocular hypertension is mediated via K+ channel opening through adenosine A2A receptor in rabbits.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Alkynes; Animals; Antihypertensive Agents; Caffeine; Decanoic Acids; Glyburide; Hydroxy Acids; Hypotonic Solutions; Intraocular Pressure; Male; Ocular Hypertension; Phenethylamines; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rabbits; Receptor, Adenosine A2A; Sodium Chloride; Time Factors; Xanthines | 2005 |
Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits.
Topics: Adenosine A1 Receptor Antagonists; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Coronary Circulation; Disease Models, Animal; Endothelium, Vascular; Glyburide; Hypercholesterolemia; Ischemic Preconditioning, Myocardial; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Potassium Channel Blockers; Potassium Channels; Rabbits; Receptor, Adenosine A1; Ventricular Pressure; Xanthines | 2007 |
Adenosine inhibits paraventricular pre-sympathetic neurons through ATP-dependent potassium channels.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Adenosine; Analgesics; Animals; Bicuculline; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Glyburide; Guanosine Diphosphate; In Vitro Techniques; KATP Channels; Male; Membrane Potentials; Neurons; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Sodium Channel Blockers; Tetrodotoxin; Thionucleotides; Tolbutamide; Triazines; Triazoles; Xanthines | 2010 |
Glucose-induced intestinal vasodilation via adenosine A1 receptors requires nitric oxide but not K(+)(ATP) channels.
Topics: Adenosine A1 Receptor Antagonists; Animals; Glucose; Glyburide; Hyperemia; Intestinal Absorption; Jejunum; KATP Channels; Male; Microscopy, Video; Microvessels; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Vasodilation; Xanthines | 2011 |
Molecular mechanisms of peritoneal dialysis-induced microvascular vasodilation.
Topics: Adenosine A1 Receptor Antagonists; Animals; Capillary Permeability; Dialysis Solutions; Diuretics, Osmotic; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Glyburide; Hypoglycemic Agents; Ileum; Mannitol; Mefenamic Acid; omega-N-Methylarginine; Peritoneal Dialysis; Peritoneum; Rats; Vasodilation; Xanthines | 2014 |
Role of the adenosine system and glucose restriction in the acute anticonvulsant effect of caprylic acid in the 6 Hz psychomotor seizure test in mice.
Topics: 3-Hydroxybutyric Acid; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Anticonvulsants; Blood Glucose; Caprylates; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Fasting; Glucose; Glyburide; Hydrogen-Ion Concentration; Hypoglycemic Agents; Male; Mice; Motor Skills; Muscle Strength; Phosphodiesterase Inhibitors; Purines; Seizures; Xanthines | 2015 |